Cargando…

Possible Biomarkers for Cancer Immunotherapy

Immune checkpoint inhibitors (ICIs) have drastically changed the clinical care of cancer. Although cancer immunotherapy has shown promise in various types of malignancies, thus far, the proportion of patients who can benefit from ICIs is relatively small. Immune-related adverse events and high cost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otoshi, Takehiro, Nagano, Tatsuya, Tachihara, Motoko, Nishimura, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678720/ https://www.ncbi.nlm.nih.gov/pubmed/31277279 http://dx.doi.org/10.3390/cancers11070935

Ejemplares similares

Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer
por: Furukawa, Koichi, et al.
Publicado: (2020)

Immunotherapy in Advanced Non-Small Cell Lung Cancers: Current Status and Updates
por: Suraya, Ratoe, et al.
Publicado: (2022)

Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy
por: Nagano, Tatsuya, et al.
Publicado: (2018)

Randomized cross-over trial of demand oxygen delivery system
por: Nagano, Tatsuya, et al.
Publicado: (2020)

Randomized cross-over trial of demand oxygen delivery system in nocturnal hypoxemia
por: Nagano, Tatsuya, et al.
Publicado: (2020)

A novel automatic cough frequency monitoring system combining a triaxial accelerometer and a stretchable strain sensor
por: Otoshi, Takehiro, et al.
Publicado: (2021)

A randomized crossover pilot study comparing the efficacy of an auto-demand oxygen delivery system with that of a conventional demand oxygen delivery system in patients with chronic respiratory failure
por: Otoshi, Takehiro, et al.
Publicado: (2021)

Society for Translational Medicine consensus (2019 edition) shows an option for postoperative management of EGFR-mutant lung cancer
por: Nagano, Tatsuya, et al.
Publicado: (2020)

Novel cancer therapy targeting microbiome
por: Nagano, Tatsuya, et al.
Publicado: (2019)

Yield of tumor samples with a large guide-sheath in endobronchial ultrasound transbronchial biopsy for non-small cell lung cancer: A prospective study
por: Katsurada, Naoko, et al.
Publicado: (2021)

Review of Therapeutic Strategies for Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer
por: Fukui, Takafumi, et al.
Publicado: (2022)

Future prospects of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and surgery for non-small cell lung cancer
por: Nagano, Tatsuya, et al.
Publicado: (2022)

Randomized single-blind comparative study of the midazolam/pethidine combination and midazolam alone during bronchoscopy
por: Katsurada, Masahiro, et al.
Publicado: (2022)

Successful Treatment of ROS1-rearranged Lung Cancer Complicated by Hypertrophic Pulmonary Osteoarthropathy with Crizotinib Therapy
por: Katsurada, Naoko, et al.
Publicado: (2019)

Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines
por: Effendi, Wiwin Is, et al.
Publicado: (2019)

The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer
por: Kiriu, Tatsunori, et al.
Publicado: (2018)

Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study
por: Kiriu, Tatsunori, et al.
Publicado: (2019)

The Notable Appearance of Pulmonary Artery Intimal Sarcoma on Positron Emission Tomography (PET)/CT
por: Tachihara, Motoko, et al.
Publicado: (2017)

Complete response in a patient with lung cancer suffering from three pembrolizumab‐induced immune‐related adverse events including retinal vasculitis
por: Mimura, Chihiro, et al.
Publicado: (2021)

A multi-center, Phase II trial of nab-paclitaxel and gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
por: Tachihara, Motoko, et al.
Publicado: (2019)

Eosinophilic Pneumonia Associated With Natalizumab In A Patient With Multiple Sclerosis: A Case Report And Literature Review
por: Yasuda, Yuichiro, et al.
Publicado: (2019)

Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review
por: Murakami, Shoko, et al.
Publicado: (2019)

Administration of JTE013 abrogates experimental asthma by regulating proinflammatory cytokine production from bronchial epithelial cells
por: Terashita, Tomomi, et al.
Publicado: (2016)

Identification of a 17 kDa protein that is a potentially novel antigen of lettuce‐associated respiratory allergy in farmers
por: Yoshioka, Junya, et al.
Publicado: (2023)

Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report
por: Kojima, Mariko, et al.
Publicado: (2018)

High expression level of serpin peptidase inhibitor clade E member 2 is associated with poor prognosis in lung adenocarcinoma
por: Dokuni, Ryota, et al.
Publicado: (2020)

Phase II study of adjuvant chemotherapy with pemetrexed and cisplatin with a short hydration method for completely resected nonsquamous non‐small cell lung cancer
por: Tachihara, Motoko, et al.
Publicado: (2020)

Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease
por: Kiriu, Tatsunori, et al.
Publicado: (2017)

Glucose metabolism‐targeted therapy and withaferin A are effective for epidermal growth factor receptor tyrosine kinase inhibitor‐induced drug‐tolerant persisters
por: Kunimasa, Kei, et al.
Publicado: (2017)

Effect of Bronchial Thermoplasty on Air Trapping Assessed by Xenon Ventilation Computed Tomography
por: Dokuni, Ryota, et al.
Publicado: (2021)

Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation
por: Suraya, Ratoe, et al.
Publicado: (2022)

Novel Multitarget Therapies for Lung Cancer and Respiratory Disease
por: Yumura, Masako, et al.
Publicado: (2020)

Novel Biomarkers for Personalized Cancer Immunotherapy
por: Shindo, Yoshitaro, et al.
Publicado: (2019)

Non‐parallel anti‐tumour effects of pembrolizumab: a case of cardial tamponade
por: Tachihara, Motoko, et al.
Publicado: (2019)

Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
por: Sato, Hiroki, et al.
Publicado: (2020)

Characteristics of the nocturnal desaturation waveform pattern of SpO(2) in COPD patients: an observational study
por: Yoshizaki, Asuka, et al.
Publicado: (2021)

Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy
por: Hazama, Shoichi, et al.
Publicado: (2018)

Caspase Recruitment Domain-Containing Protein 9 Expression is a Novel Prognostic Factor for Lung Adenocarcinoma
por: Miwa, Nanako, et al.
Publicado: (2020)

Group 2 Innate Lymphoid Cells and the House Dust Mite-Induced Asthma Mouse Model
por: Yasuda, Yuichiro, et al.
Publicado: (2020)

Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases
por: Effendi, Wiwin Is, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6tj1pjn268rqh1so3d0chseisk